Synthesis and evaluation of new oxamniquine derivatives

International Journal of Pharmaceutics

Volumn 233, Issue 1-2, 2002, Pages 35-41

  Filho, Silvio Barberato ^a   Gargioni, Cybele ^b   Silva Pinto, Pedro Luiz ^b   Chiodelli, Silvia Gabriel ^b   Gurgel Vellosa, Sylvia Amaral ^b   Da Silva, Rita Maria ^b   Da Silveira, Maria Amélia Barata ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Drug design; Oxamniquine; Prodrug; Schistosoma mansoni; Schistosomicide

Indexed keywords

ACETALDEHYDE; ALIPHATIC AMINE; ANTISCHISTOSOMAL AGENT; FORMALDEHYDE; METHANOL DERIVATIVE; OXAMNIQUINE; OXAMNIQUINE DERIVATIVE; PARAFORMALDEHYDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYCLIZATION; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANIMALS; DRUG EVALUATION, PRECLINICAL; MALE; MICE; OXAMNIQUINE; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037148691     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00917-6     Document Type: Article

References (38)

1. Oxamniquine
2. 4-substituted 2,7- and 2,8-bis(trifluoromethyl)quinolin-4′-amines
3. Drug resistance in schistosomiasis: A review
4. Pro-drugs as drug delivery systems. XVIII. Bioreversible derivatization of allopurinol by N-aminomethylation to effect enhanced dissolution rates
5. Recent advances in schistosomiasis
6. Success rates for new drugs entering clinical testing in the United States
7. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment
8. Schistosomiasis
9. Studies with the schistosomicide oxamniquine (UK-4271) I. Activity in rodents and in vitro
10. The action of UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative, against mature schistosomes in rodents and primates
11. Laboratory trials on oxamniquine (UK-4271), a candidate schistosomicide
12. The drug development process: Introduction and overview
13. Mannich reactions of nucleophilic aromatic compounds involving aminals and α-amino ethers activated by chlorosilane derivatives; catalyst by chlorotrimethylsilane
14. Synthesis and antihelminthic activity of Mannich bases of 5-chlorosalicylic acid hydrazide
15. Experimental chemoprophylaxis against schistosomiasis. I: Introduction and rationale
16. Potential antiinfective agents. I. Quinoline, phenolic, and β-aminoketone derivatives
17. Selective aminomethylation of N-propargylanilines
18. Malaria: New developments in treatment and prevention
19. The oogram method for the screening of drugs in schistosomiasis mansoni
20. Experimental chemotherapy of schistosomiasis mansoni
21. Schistosomicidal activity of alkylaminooctanethiosulfuric acids
22. Innovation in the pharmaceutical industry: Perceptions and practices
23. A simple method of estimating fifty per cent endpoints
24. Zur chemie und wirkungsweise aminomethylierender carcinostatica
25. Antimalarial activity of Mannich bases derived from 4-(7′-bromo-1′,5′-naphthyridin-4′-ylamino) phenol and 4-(7′-trifluoromethylquinolin-4′-ylamino)phenol against Plasmodium falciparum in vitro
26. Synthesis and antibacterial activities of some Mannich bases from coumarin derivatives
27. The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel
28. Schistosomiasis drug therapy and treatment consideration
29. Controle da esquistossomose no Brasil
30. 4-Aminoquinolines and Mannich bases
31. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and Schistosoma mansoni in mice
32. Neue herzwirksame β-aminoketone
33. Advances in the chemistry of Mannich bases
34. Zusammenhänge zwischen der chemischen struktur von Mannich-basen mit und ohne stickstofflostgruppen und ihrer cytostatischen wirksamkeit auf das Ehrlich-ascites-carcinom der weiken maus